Samuel S Phen

Cachexia is Prevalent in Patients with Hepatocellular Carcinoma and Associated with Worse Prognosis.

J. Marrero, P. Iyengar, Ju Dong Yang, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study.

M. Kudo, P. Galle, N. Nishida, 2022, European journal of cancer.

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

Yuehua Wu, M. Kudo, P. Galle, 2022, Cancers.